KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Free Cash Flow (2016 - 2025)

Cme (CME) has disclosed Free Cash Flow for 17 consecutive years, with $1.1 billion as the latest value for Q4 2025.

  • On a quarterly basis, Free Cash Flow rose 11.06% to $1.1 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $4.2 billion, a 16.6% increase, with the full-year FY2025 number at $4.2 billion, up 16.6% from a year prior.
  • Free Cash Flow was $1.1 billion for Q4 2025 at Cme, up from $949.7 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $1.1 billion in Q1 2025 to a low of $460.1 million in Q2 2021.
  • A 5-year average of $820.4 million and a median of $854.8 million in 2023 define the central range for Free Cash Flow.
  • Biggest YoY gain for Free Cash Flow was 128.01% in 2021; the steepest drop was 51.59% in 2021.
  • Cme's Free Cash Flow stood at $641.0 million in 2021, then surged by 49.31% to $957.1 million in 2022, then increased by 6.94% to $1.0 billion in 2023, then fell by 3.11% to $991.7 million in 2024, then rose by 11.06% to $1.1 billion in 2025.
  • Per Business Quant, the three most recent readings for CME's Free Cash Flow are $1.1 billion (Q4 2025), $949.7 million (Q3 2025), and $1.0 billion (Q2 2025).